Mallinckrodt PLC

Pharmaceuticals
United Kingdom
2016 Revenue (US$ Millions)$3,381
Revenue Growth (%)1.01%
Net Income (US$ Millions)$325
Earnings Per Share (US$)NA
EPS Growth Rate (%)NA
Profit Margin9.60%
Total Equity (US$ Millions)$5,311
Return on Equity (%)6.55%
Long Term Debt (US$ Millions)NA
Debt To Equity Ratio (%)NA
Total Assets (US$ Millions)$3,557
Current Assets (US$ Millions)NA
Current Liabilities (US$ Millions)NA
Cost of Goods Sold (US$ Millions)$1,180
Inventory Turnover2.81